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Clouston syndrome or hidrotic ectodermal dysplasia (HED) is a rare dominant genodermatosis characterized
by palmoplantar hyperkeratosis, generalized alopecia and nail defects. The disease is caused by mutations in
the human GJB6 gene which encodes the gap junction protein connexin30 (Cx30). To gain insight into the
molecular mechanisms underlying HED, we have analyzed the consequences of two of these mutations
(G11R Cx30 and A88V Cx30) on the functional properties of the connexons they form. Here, we show that
the distribution of Cx30 is similar in affected palmoplantar skin and in normal epidermis. We further demon-
strate that the presence of the wild-type protein (wt Cx30) improves the trafficking of mutated Cx30 to the
plasma membrane where both G11R and A88V Cx30 co-localize with wt Cx30 and form functional intercellular
channels. The electrophysiological properties of channels made of G11R and A88V Cx30 differ slightly from
those of wt Cx30 but allow for dye transfer between transfected HeLa cells. Finally, we document a gain of
function of G11R and A88V Cx30, which form functional hemichannels at the cell surface and, when
expressed in HeLa cells, generate a leakage of ATP into the extracellular medium. Such increased ATP
levels might act as a paracrine messenger that, by altering the epidermal factors which control the prolifer-
ation and differentiation of keratinocytes, may play an important role in the pathophysiological processes
leading to the HED phenotype.
INTRODUCTION
Clouston syndrome, also referred to as hidrotic ectodermal
dysplasia (HED) (MIM 129500), is a rare genetic disorder
characterized by three major clinical signs: generalized alope-
cia, nail dystrophy and palmoplantar hyperkeratosis (1,2).
Patients present normal sweating and their cutaneous signs
may be accompanied by other symptoms such as mental retar-
dation (3). The syndrome is transmitted in a dominant, auto-
somal manner and mainly affects the French-Canadian
populations (4). A positional cloning study showed that
affected individuals from one large French family presented
a point mutation (31G . A) in the coding region of the
GJB6 gene, which codes for the gap junction protein con-
nexin30 (Cx30) (5). This mutation leads to the substitution
of one amino acid on the N-terminal tail of the protein
(mutation G11R). The same study showed that this mutation
was present in patients of most families affected by Clouston
syndrome, whereas other affected families presented another
point mutation (263C . T) leading to an amino acid substi-
tution (A88V) in the second transmembrane domain of
Cx30. More recently, a third mutation (110T . A) leading
to the amino acid substitution (V37E) has been described in
one patient (6).
Connexins (Cx) are a family of proteins that play an import-
ant role in cell-to-cell communication, as they constitute the
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protein subunits of gap junctions. Connexins form hexameres
called connexons, which interact with connexons from adja-
cent cells to form a complete intercellular gap junction
channel that provides a pathway for both ionic and metabolic
coupling between the participating cells. More than 20 differ-
ent connexins have been described in mammals so far, each
with specific tissue distribution, electrophysiological charac-
teristics and regulatory properties. Still, all connexins share
a similar structure comprising four transmembrane domains,
and differ mainly by the size and nature of their C-terminal,
intracellular tail (7,8). Mutations in some connexins are
responsible for genetic diseases, and different mutations of
the same connexin can generate a variety of phenotypes (9).
For example, Cx26 or Cx31 are responsible for epidermal
disorders and/or hereditary hearing impairment [viz. kera-
titis-ichthyosis-deafness syndrome, Vohwinkel syndrome and
non-syndromic hearing impairment for Cx26; erythrokerato-
dermia variabilis (EKV) and nonsyndromic hearing impair-
ment for Cx31]. Such is also the case for Cx30. Indeed,
another point mutation of Cx30 (T5M) is responsible for a
recessive form of profound sensorineural deafness (10).
Even though the number of connexin mutations known to be
responsible for genetic diseases continues to increase, the mol-
ecular mechanisms underlying most connexin-related geno-
dermatosis remain unclear. In an attempt to understand how
the G11R and A88V mutations of the human Cx30 generate
a skin phenotype, skin of HED patients was immunostained
to determine the localization of the wild-type and mutated
forms of Cx30 within the epidermis. We also studied the func-
tional properties of the skin-related Cx30 mutations using two
different expression systems, to assess how the mutated pro-
teins compare and interact with the wild-type Cx30 (wt
Cx30). Our data show that both the G11R and A88V variants
retain the ability to form intercellular channels, but also make
functional hemichannels that may lead to the abnormal release
of paracrine signals. These findings provide novel insights on
a possible pathophysiological mechanism whereby Cx30
mutations cause HED.
RESULTS
Cx30 is similarly distributed in normal and
HED epidermis
The affected epidermis of Clouston patients (Fig. 1C) showed
a marked thickening of the stratum corneum (hyperkeratosis),
and the number of living keratinocytes seems slightly
increased (mild acanthosis), when compared with normal
palmoplantar human epidermis (Fig. 1A). The thicker stratum
corneum was compact and did not feature cell nuclei (orthoker-
atosis), indicating proper terminal differentiation of the affected
keratinocytes. In both normal, as previously described (11), and
HED palmoplantar skin, Cx30 staining was restricted to kerati-
nocytes of the upper layers of the stratum spinosum and to those
of the stratum granulosum (Fig. 1B and D), as well as in sweat
gland ducts (data not shown). No detectable intracellular
accumulation of Cx30 was observed in the cytoplasm of HED
keratinocytes, suggesting that mutant proteins were either
rapidly degraded or properly transferred to the membrane, simi-
larly to the wt Cx30.
The same membrane sites contain both
mutant and wt Cx30
The connexin-deficient HeLa cell line was transiently trans-
fected with plasmids driving the expression of different
forms of Cx30. The presence of a V5 tag on the G11R and
A88V constructs allowed us to distinguish between the
mutated and the wild-type forms of the protein. Wt Cx30
was not recognized by the anti-V5 antibody due to the pre-
sence of a stop codon preventing the translation of the tag,
but was recognized by the anti-Cx30 antibody and was
detected as green fluorescence, thanks to a FITC-labelled
anti-rabbit antibody. On the other hand, G11R and A88V
Figure 1. Cx30 shows a similar localization in normal and HED palmoplantar
epidermis. (A) Immunolabelling of palm epidermis of a control individual
(higher magnification in (B) shows that wt Cx30 was distributed in the
keratinocytes of the upper spinous layers (arrow) and in those of the stratum
granulosum. (C) Affected palm epidermis of a HED patient, who was hetero-
zygous for the G11R mutation, shows a thickening of the stratum corneum and
a mild acanthosis. (D) A higher magnification of the affected epidermis shows
the normal localization of both wt and mutated forms of Cx30 in the stratum
granulosum and stratum spinosum (arrow). Sections were counterstained with
haematoxylin. Scale bar 100 mm in A and C, and 20 mm in B and D.
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Figure 2. Wild-type and mutant forms of Cx30 co-localize in transfected HeLa cells. The wild-type form of the transfected protein lacked the V5 tag, which was
present on the mutated forms. For this reason, wt Cx30 was only recognized by the anti-Cx30 antibody (green fluorescence), whereas G11R and A88V Cx30
were recognised by both the anti-Cx30 and the anti-V5 antibodies (green and red fluorescence). (A) Cells transfected with wt Cx30 show the protein (green
fluorescence) at membrane interfaces (arrow). In contrast, cells transfected with either G11R Cx30 (B) or A88V Cx30 (C) exclusively show a cytoplasmic local-
ization of the protein (green and red fluorescence). (D and E) When co-transfected with wt Cx30, the two mutated proteins (green and red fluorescence) were
detected at the interface of cells (arrows). Scale bar 10 mm. Nuclei are stained with DAPI (blue fluorescence).
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Cx30 were recognized by both the anti-Cx30 and the anti-V5
antibodies, and were detected as both green (FITC) and red
fluorescence, thanks to a Cy3-labelled secondary anti-mouse
antibody. Thus, a red labelling exclusively indicated a
mutant Cx30. As previously reported (12), transfections with
wt Cx30 led to large areas of staining at the membrane inter-
face of HeLa cells (Fig. 2A). On the other hand, HeLa cells
transfected with G11R or A88V Cx30 showed no obvious con-
centration of the proteins at the membrane (Fig. 2B and C).
However, the cytoplasm of these cells was evenly stained in
red, indicating an accumulation of the mutated connexins
and making it difficult to exclude that limited amounts of
the protein were targeted to the plasma membrane. After
co-transfections of equal amounts of wild-type and mutated
Cx30, we observed that the mutated connexins were
co-expressed in both cytoplasm and membranes of the very
same cells (Fig. 2D and E).
Mutant forms of Cx30 allow for dye coupling of
HeLa cells as wt Cx30
To determine the permeability of the channels made of wild-
type and mutated Cx30, we microinjected neurobiotin (NB,
MW ¼ 287 Da, 1 positive charge) and Lucifer yellow (LY,
MW ¼ 443 Da, 2 negative charges) in HeLa cells that had
been transiently transfected either for one form of the con-
nexin (wt Cx30, G11R Cx30 or A88V Cx30) or with a com-
bination of the wild-type and a mutated form (wt plus G11R
Cx30 or wt plus A88V Cx30). NB revealed coupling
between HeLa cells, irrespective of the Cx30 form that had
been transfected (Fig. 3 and Table 1). In most cases, the
tracer diffused between three and 10 adjacent cells. No signifi-
cant difference in the incidence of coupling was revealed
between the five groups of cells which were compared.
However, cells transfected for A88V Cx30 were often
uncoupled and featured coupling limited to a median
number of six cells labelled by NB after each injection
(n ¼ 12). In contrast, cells transfected for wt Cx30 were
almost consistently coupled (the median number of cells
labelled after each injection was 10, n ¼ 9) (Table 1).
Co-transfection of wt Cx30 with either G11R Cx30 or A88V
Cx30 did not markedly alter this pattern (Fig. 3 and Table 1).
The dependence of this coupling on junctional channels was
established by assessing the lack of intercellular transfer
of a 40 kDa molecular weight dextran, which was always
retained within the individual cells that had been microin-
jected (Fig. 3F).
We also probed the transfected cells for exchange of LY.
This tracer, which has a larger size and molecular weight
than NB and a different electrical charge, may barely permeate
Cx30 channels (13), presumably because its hydrated diameter
closely corresponds to the pore of the gap junction channels
(14). HeLa cells transfected with wt Cx30 showed a much
reduced coupling incidence and extent when tested with LY
than with NB. Thus, coupling was observed only between 2
and 4 cells after about 50% of the injections (Fig. 3 and
Table 1). G11R Cx30 and A88V Cx30 also allowed for
limited LY transfer after about 45% of the injections. Cells
co-transfected for both the wt and a mutated form of Cx30
Figure 3. The wild-type and mutated forms of Cx30 permit a differential
transfer of NB and LY between transfected HeLa cells. Left panel: injections
of NB-dextran. (A) After a 5 min injection, most HeLa cells expressing the
wild-type form of Cx30 exchanged NB with 5–10 of their neighbours.
(B and C) A comparable dye coupling was observed between cells transfected
with either G11R (B) or A88V Cx30 (C), or co-expressing the wild-type form
of Cx30 and one of the mutations that are observed in Clouston syndrome
(D: wt þ G11R Cx30; E: wt þ A88V Cx30). (F) No cell-to-cell transfer of a
40 kDa dextran was observed between the very same cells that had exchanged
NB (the cell illustrated is the same shown in A). Right panel: injections of
LY under conditions similar to those used for NB. (G) Most HeLa cells expres-
sing the wild-type form of Cx30 exchanged LY with only 2–3 of their neigh-
bours. (H and I) A comparable transfer was observed between cells
transfected with either G11R (H) or A88V Cx30 (I). (J and K) LY transfer
was not significantly altered between HeLa cells co-expressing wt Cx30 and
either the G11R Cx30 (J) or the A88V Cx30 mutated form of the connexin
(K). Scale bar 15 mm.
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did not behave differently than the cells transfected with only
one form of the connexin (Fig. 3 and Table 1).
G11R and A88V Cx30 form functional intercellular
channels in paired Xenopus oocytes
The ability of G11R and A88V Cx30 to form functional
channels was tested using paired Xenopus oocytes, in
which intercellular currents developed by the injected con-
nexin RNAs can be analyzed (15). The translational compe-
tence of the in vitro transcribed RNAs was examined in a
rabbit reticulocyte lysate in the presence of [35S]methionine
(Fig. 4A). Both wild-type and mutated RNAs directed the
synthesis of a major polypeptide band that, as in other
studies (16), migrated with an electrophoretic mobility that
differed from that predicted for a molecular mass of
30 kDa (Fig. 4A, lanes 1–3). Oocyte pairs expressing
either G11R or A88V Cx30 efficiently assembled homotypic
channels that resulted in conductance levels comparable
with those recorded with wt Cx30 (Fig. 4B). We noticed,
however, that the A88V mutation exhibited a reduced pro-
pensity to form gap junction channels with respect to
either wt or G11R (P , 0.025). Thus, homotypically paired
oocytes injected with wt and G11R Cx30 received the
same amount of RNA (either 1 or 4 ng/cell, depending on
the experiment), whereas in the case of A88V Cx30 consist-
ent and reliable measurements of junctional conductance
were obtained only when higher RNA amounts (32–40 ng/cell)
were injected. Both G11R and A88V Cx30 retained the
ability to interact equally well with wt Cx30 in heterotypic
configuration and yielded levels of junctional conductance
that were not different from those of homotypic wt–wt pairs
(data not shown).
Homotypic G11R and A88V channels exhibit distinct
voltage gating properties
To test whether the channels made by the two mutated forms
of Cx30 had altered electrical properties and gating behaviour,
we examined their response to voltage gating. The junctional
currents of homotypic channels made of wt Cx30 decayed
over time for potentials .40 mV (Fig. 5A), in agreement
with previous studies (17,18), and the rate of channel
closure increased with Vj. Boltzmann plots of the normalized
steady-state conductance values measured at the end of the
imposed pulses showed a symmetrical response to voltage
(Table 2). Oocyte pairs expressing G11R Cx30 channels dis-
played a similar voltage dependence (Fig. 5C), as reflected
by comparing the values of transjunctional voltage (V0)
required to elicit a conductance midway between Gjmax and
Gjmin (Table 2). In contrast, at the larger Vjvalues, the residual
conductance (Gjmin) of G11R Cx30 homotypic channels was
significantly increased (P , 0.01) with respect to that of wt
Cx30 for both depolarizing and hyperpolarizing pulses
(Fig. 5D and Table 2). The voltage gating behaviour of homo-
typic channels made of A88V Cx30 revealed a more pro-
nounced sensitivity to voltage. Thus, junctional currents
started to decay at potentials .+20 mV (Fig. 5E), and,
accordingly, the V0 values were lower (P , 0.01), when com-
pared with those of either wt or G11R Cx30 channels
(Table 2).
G11R and A88V Cx30 form voltage-activated
hemichannels
As mentioned in the Materials and Methods section, the injec-
tion of RNAs encoding G11R and A88V Cx30 was toxic for
oocytes, unless the Ca2þ concentration of the culture
medium was raised to 2.9 mM, suggesting the presence of
functional hemichannels. To test for the presence of such
hemichannels, we recorded whole cell currents of single
Xenopus oocytes, in the presence of 2.9 mM Ca2þ and in
response to depolarizing voltage steps. As expected, antisense
controls (Fig. 6A) displayed no evidence of voltage-activated
currents. Oocytes injected with RNA for wt Cx30 showed
small currents at the more positive potentials (Fig. 6B), indi-
cating the formation of some hemichannels, as previously
reported (19). Under the same experimental conditions,
large, voltage-activated outward currents were consistently
induced when oocytes expressing G11R Cx30 were stepped
to voltages.220 mV (Fig. 6C). Similar results were obtained
with A88V Cx30 (data not shown). Quantitation of the
current–voltage relationship demonstrated that, at þ60 mV,
A88V Cx30 and G11R Cx30 featured voltage-activated
currents of hemichannels that were increased 3- and 5-fold,
respectively, over those measured in oocytes expressing wt
Cx30 (Fig. 6D).
Table 1. The wt and mutated forms of Cx30 mediate a differential transfer of LY and NB between transfected HeLa cells
Transfected HeLa cells No. cells injected No. cells labelled by
Lucifer yellow Neurobiotin
LY / NB 1a 2 3 1a 2 3
Wt Cx30 16/9 7 5 4 0 2 7
G11R Cx30 18/11 10 7 1 2 3 6
A88V Cx30 18/12 10 8 0 3 7 2
G11R Cx30 þ wt Cx30 17/13 11 4 2 2 4 7
A88V Cx30 þ wt Cx30 18/11 10 5 3 1 3 7
aUncoupling.
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Mutant Cx30 causes ATP leakage in the extracellular
medium and induces cell suffering
To assess the permeability of the hemichannels formed by
G11R and A88V Cx30, we tested HeLa cells transfected for
each of these mutated Cx30 for ATP leakage in the extra-
cellular medium, and assessed whether this leakage was
dependent on connexin hemichannels. Twenty-four hours
after transfection, the relative luciferase activity indicating
ATP release by transfected cells was expressed as percentage
of that observed in the culture medium of mock-transfected
control HeLa cells which were exposed to the transfection
reagents without DNA. Mock-transfected cells, as well
as cells that were transfected with a plasmid lacking the
Cx30 insert (pcDNATM3.1/V5-His), and cells transfected
with either wt Cx30 (wtCx30-pcDNATM3.1/V5-His) or
the deafness-related T5M mutated Cx30 (T5MCx30-
pcDNATM3.1/V5-His) showed similar levels of extracellular
ATP (Fig. 7). In contrast, HeLa cells transfected with either
G11R or A88V Cx30 (G11RCx30-pcDNATM3.1/V5-His and
A88VCx30-pcDNATM3.1/V5-His), as well as cells doubly
transfected with one of the mutated forms plus wt Cx30
showed levels of extracellular ATP that were 2–3 times
greater (P , 0.001) than those observed in mock-transfected
cells (Fig. 7). This increased ATP release was reduced to
control levels (P , 0.001) following a 30 min exposure to
a-glycyrrhetinic acid, a liquorice derivative that is widely
used as an inhibitor of gap junction channels (Fig. 7). In
order to make sure that such an increase in ATP release was
not simply due to a higher proportion of dead cells that had
been transfected with mutated Cx30, we have counted the
relative number of viable cells [propidium iodide (PI)-negative]
at 24 and 48 h following transfection. While no significant cell
suffering was observed at 24 h following transfection, HeLa
cells expressing the mutated forms of the protein presented a
significantly greater number of PI-positive cells 48 h after
transfection (Table 3).
DISCUSSION
Clouston syndrome or HED is a rare genodermatosis that
mainly affects palmoplantar skin as well as ectodermic appen-
dages (1). This disease is caused by mutations in the coding
Figure 4. Wild-type, G11R and A88V Cx30 form functional intercellular
channels in paired Xenopus oocytes. (A) Translational competence of syn-
thetic RNAs encoding wt, G11R and A88V Cx30. Experimental conditions
are indicated at the bottom of each lane. The molecular mass (in kDa) and
migration of the protein standards are shown on the left edge of the gel.
The in vitro translated products were separated on a 13% SDS–polyacryl-
amide gel, and detected by fluorography. Each RNA directed the synthesis
of a major polypeptide product migrating with a similar electrophoretic mobi-
lity and an apparent molecular weight of 28 kDa. (B) Oocytes were injected
with either RNA (wt, G11R or A88V) or water and paired for 8–24 h before
measuring junctional conductance (Gj) by dual voltage clamp. All cells were
pretreated with antisense Cx38 oligonucleotides to deplete oocytes of the
endogenously expressed connexin. Water-injected cells showed no detectable
coupling under these conditions. G11R and A88V retained the ability to
assemble homotypic junctional channels. Values are mean + SEM of 34–
39 oocyte pairs from at least five independent experiments. P , 0.025
versus either wt or G11R.
Figure 5. Homotypic channels composed of wt, G11R and A88V Cx30 are
gated by transjunctional voltage. (A, C, E) Time-dependent decay of junc-
tional currents developed by pairs of antisense-treated oocytes injected with
RNAs coding for the specified constructs. The currents reflect voltage-
induced closure of the cell-to-cell channels for transjunctional potentials
(Vj) .+40 mV whether those channels were made of wt (A), G11R (B) or
A88V Cx30 (E). (B, D, F) Plots describe the relationship of Vj as a function
of steady-state junctional conductance, normalised to the values obtained at
+20 mV. Solid lines represent the best fits to Boltzmann equations whose par-
ameters are given in Table 2. For the sake of comparison, the dashed lines in
(D) (G11R) and (F) (A88V) show the Boltzmann curve of Cx30 wt (B).
Results represent mean+ SEM of 5–9 oocyte pairs from at least two indepen-
dent experiments; in many cases, the error bars are contained within the plot
symbols.
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region of the GJB6 (Cx30) gene, but the mechanism whereby
these mutations cause HED is unknown. In order to under-
stand such mechanisms, we have studied the cellular transport
of the G11R and A88V mutated forms of Cx30 as well as the
functional properties of the channels formed by these mutated
proteins in the presence and absence of wt Cx30.
By analogy to what has been reported in other genetic
diseases associated to connexin mutations (20–22), Cx30
mutations may cause HED by altering the transport of the
protein to the cell surface. In this study, we have first observed
that the localization of Cx30 in palmoplantar skin of patients
with HED is alike that of observed in unaffected individuals,
with no detectable accumulation of the protein in the cyto-
plasm of keratinocytes. We have confirmed that, as previously
described (12), both G11R and A88V are abundant in the cyto-
plasm of transfected HeLa cells. However, under conditions
that recapitulate in vitro the heterozygous state of the affected
individuals, i.e. after co-transfection with the native form of
the protein, both G11R and A88V Cx30 were readily observed
at membrane interfaces between cells. A sizeable fraction of
the mutated forms of Cx30 which we studied were transported
to the membranes of HeLa cells, both in the presence or in the
absence of wt Cx30, as indicated by our dye injection exper-
iments. Together, these results indicate that the two mutated
forms of Cx30 that are associated with HED form cell-to-
cell channels, but their accumulation at the plasma membrane
is limited and may be masked, in immunostaining exper-
iments, by their larger accumulation in the cytoplasm. It
remains to be established whether this accumulation indicates
some specific perturbation in the intracellular transport of
the mutated proteins, as proposed in a previous report (12),
or merely reflects a saturation of the transport machinery of
the cells when high levels of the proteins are induced by trans-
fection. It is noticeable that the presence of the T5M mutation
(responsible for nonsyndromic autosomal dominant deafness
at the DFNA3 locus) has been shown not to disturb the traf-
ficking of the protein in transfected cells (12). This indicates
that different mutations may have different effects on Cx30
trafficking.
In our experiments, dye coupling was more extensive when
assessed with NB than when assessed with LY. Although
the passage of the former tracer through Cx30 channels is
in agreement with previous reports (23), that of LY was not
anticipated since previous studies had indicated that human
and mouse Cx30 may not allow for the transfer of this
molecule (12,13). Several differences between our and these
previous studies may explain this difference. First, our human
Cx30 constructs contained a small, 29 amino acid V5-His tag,
whereas previous studies tested the connexin tagged with the
much larger, 273 amino acid green fluorescent protein (12),
which could sterically hinder the entrance of LY into the
hydrophilic centre of the junctional channels. Second, differ-
ent levels of Cx30 expression between the HeLa cells stably
transfected with mouse Cx30 (13) and our HeLa cells,
which were transiently transfected with human Cx30, may
also be relevant, since Cx30 forms low conductance channels
(13,24), which favour the passage of small tracers (16), par-
ticularly when expressed in limited number. Thus, at variance
with the deafness-related T5M mutated form of Cx30, which
has been reported to form poorly permeant channels (12),
both G11R and A88V Cx30 allowed for the easy passage of
NB between adjacent HeLa cells. Co-expression of these pro-
teins with wild-type Cx30 did not reveal an obvious dominant
negative effect, inasmuch as dye injection showed frequent
coupling of cells expressing a mixture of the two connexins.
Quantitative evaluation revealed minor differences in the
extent of dye transfer of the different cell groups that were
compared, whereas junctional conductance was larger in
cells connected by wild-type Cx30 than in cells expressing
the G11R Cx30 form, or co-expressing either the latter
protein or A88V Cx30 together with the native form of the
connexin, suggesting subtle differences in the permeability
of the resulting cell-to-cell channels. The electrophysiological
analysis of paired Xenopus oocytes further revealed that the
channels made by A88V Cx30 differed from those made by
the other Cx30 forms in their voltage gating properties.
Since the macroscopic junctional conductance (Gj) between
two cells (Gj ¼ n  P0  gj) is the product of the number of
channels open at any given time (n ) times the single
channel open probability (P0) times the single channel
unitary conductance (gj), the lower values recorded in homo-
typic A88V pairs could be due to either one of two mechan-
isms, which are not mutually exclusive. First, the A88V
mutation leads to a reduced inter-connexon affinity in
Table 2. Parameters of homotypic channels composed of wt, G11R or A88V Cx30 in paired Xenopus oocytes
Channel Vj Gjmax Gjmin A n V0
wt–wt (n ¼ 9) þ 1 0.17+ 0.01 0.19+ 0.02 4.7+ 0.6 53+ 1
2 1 0.17+ 0.01 0.17+ 0.02 4.3+ 0.4 51+ 2
G11R–G11R (n ¼ 6) þ 1 0.36+ 0.04 0.14+ 0.01 3.5+ 0.3 52+ 2
2 1 0.31+ 0.02 0.15+ 0.01 3.8+ 0.3 48+ 3
A88V–A88V (n ¼ 5) þ 1 0.21+ 0.01 0.19+ 0.01 4.9+ 0.1 41+ 2
2 1 0.19+ 0.05 0.16+ 0.02 4.1+ 0.4 42+ 1
To quantify the voltage gating characteristics of the different channels, the oocyte pairs presented in Fig. 5 were used to calculate the parameters
derived from the best fits to the Boltzmann equation (see Materials and Methods). Gjmin is the minimum conductance value estimated from the
Boltzmann fit, and V0 is the voltage at which the half-maximal decrease of Gj is measured. The cooperativity constant (A ), reflecting the voltage
sensitivity of the channel, can also be expressed as the equivalent number (n ) of electron charges moving through the transjunctional voltage field.
The plus and minus signs for Vj refer to the polarity of the transjunctional potential. These parameters were derived from oocyte pairs whose Gj
was 3.9+ 0.6 mS (n ¼ 9) for wt; 3.1+ 0.8 mS (n ¼ 6) for G11R and 2.9+ 1.5 mS (n ¼ 5) for A88V (mean+ SEM).
P , 0.01 versus the respective parameters of wt–wt channels.
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homotypic configuration, which results in a poor efficiency in
channel formation, as previously shown for other mutant con-
nexins (25,26). This possibility is supported by the observation
that larger amounts of microinjected RNA (with respect to wt
and G11R) are needed to obtain consistent levels of junctional
conductance and by the finding that such a functional deficit
was reversed by constructing heterotypic wt-A88V channels,
which were as efficiently assembled as in the case of homo-
typic wt–wt pairs. Second, this amino acid substitution
affects intrinsic channel properties that have an impact on
the recorded levels of Gj, for example, favouring a closed
state in the absence of transjunctional potential (27), as well
as reducing the open time probability and/or unitary conduc-
tance, as demonstrated for other disease-causing connexin
mutations (28,29). Further work at the single channel level
is needed to distinguish between these possibilities. At any
rate, the two Cx30 mutations we studied did not abolish inter-
cellular coupling nor did they exert a major dominant negative
effect on the junctional channels. Therefore, a decrease in cell-
to-cell coupling cannot easily account for a pathogenetic role
in the development of HED.
After the injection of single oocytes with either G11R or
A88V Cx30 RNA, we unexpectedly observed a depigmenta-
tion of the cells, a loss of their membrane potential and, in
most cases, their lysis, suggesting that, similarly to other
wild-type and mutated connexins (30–32), the mutated
species of Cx30 formed functional hemichannels in the non-
junctional membrane. Although we did not examine in detail
the long-term effect of the expression of Cx30 mutants on
HeLa cells viability, we suspect, as previously described for
other connexins (33,34), that these two mutations exerted
adverse effects also in this expression system. Thus, we
were unable to derive clones stably expressing any one of
them and observed higher proportions of dead cells over
time in the case of HED transfectants, as indicated by the
increased number of PI-positive cells 48 h after transfection.
Figure 6. G11R and A88V mutations of Cx30 lead to the formation of func-
tional hemichannels in single Xenopus oocytes. (A–C) Whole-cell membrane
currents (Im) were measured in single oocytes co-injected with the different
Cx30 RNAs and an oligonucleotide antisense to Xenopus Cx38 (see Materials
and Methods). Cells were initially clamped at a membrane potential (Vm) of
240 mV and depolarizing steps lasting 10 s were applied in 20 mV increments
up to þ60 mV (top traces in A and B). At positive membrane potentials,
expression of both G11R (C) and A88V (data not shown) resulted in the acti-
vation of an outward current that was not seen in either the antisense-treated
controls (A) or the cells injected with wt Cx30 RNA (B). (D) Current–voltage
relationships were determined for oocytes injected with antisense oligonucleo-
tides (open circles), wt Cx30 (solid circles), G11R Cx30 (solid squares), or
A88V Cx30 (open squares) RNAs plus antisense. Peak current values above
holding currents (DIm) were calculated and plotted as a function of Vm. Start-
ing at a Vm of 0 mV, the mean amplitude of hemichannel currents recorded in
G11R- and A88V-injected cells was significantly different from that of control
and wt Cx30 oocytes. P , 0.01 and P , 0.005. Results are shown as
mean + SEM from at least two independent experiments; in many cases,
the error bars are contained within the plot symbols. Antisense (n ¼ 12); wt
(n ¼ 12); G11R (n ¼ 14) and A88V (n ¼ 4).
Figure 7. ATP release is increased after transfection of HeLa cells for either
G11R or A88V Cx30. Extracellular ATP levels were evaluated by a luciferase
activity assay and expressed relative to those measured in control cells
that were exposed to the transfection reagent without plasmid DNA
(100%). Cells transfected with wt Cx30 with T5M Cx30 as well as without
a connexin cDNA (wtCx30-pcDNATM3.1/V5-His, T5MCx30-pcDNATM3.1/
V5-His and pcDNATM3.1/V5-His, respectively) showed comparable extra-
cellular ATP levels. Cells transfected with G11R or with A88V Cx30
(G11RCx30-pcDNATM3.1/V5-His and A88VCx30-pcDNATM3.1/V5-His,
respectively) alone or co-transfected with one of these mutated constructs
plus wt Cx30 showed a much larger ATP release, which was reduced to
control levels after exposure to the uncoupling drug a-glycyrrhetinic acid.
Values are mean + SEM for n . 6 experiments. P , 0.005 significantly
different from the mock-transfected control.
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It should be noted, however, that HeLa cells were cultured in
the presence of 1.9 mM Ca2þ, a concentration well above that
of the standard MB culture medium for oocytes, which could
reduce hemichannel activity. The connexin nature of these
hemichannels is supported by several lines of evidence.
First, oocyte death could be prevented by raising the extra-
cellular Ca2þ concentration that, as already reported for
other connexin isoforms (35–39), strongly inhibits hemichan-
nel activity. Second, oocytes expressing the mutated Cx30
exhibited large, voltage-activated outward currents that were
barely detectable, even at the more positive depolarizing
steps, in either oocytes injected with wt Cx30 RNA or
control cells (all tested in high external Ca2þ conditions).
Third, the presence of open hemichannels made of mutated
Cx30 was consistent with the finding of a large ATP leakage
from HeLa cells that had been transfected with either G11R
or A88V Cx30, alone or together with wild-type Cx30, but
not from cells that expressed wt Cx30 or the deafness-
related T5M mutation of this protein. Finally, the ATP
release in the extracellular medium could be prevented by
incubating HeLa cells in the presence of the gap junction
blocker a-glycyrrhetinic acid. We are aware that these liquor-
ice derivatives are not entirely specific for gap junction block-
ade and that it remains possible that ATP release occurs via
other types of a-glycyrrhetinic acid-sensitive channels,
whose expression may have been induced in HeLa transfected
for a mutated Cx30 and that we have not provided a definitive
proof that hemichannels are the only source of ATP release.
Since the number of viable cells expressing a mutated form
of Cx30 was similar to that of HeLa transfected with wt
Cx30 at 24 h after transfection, cell death cannot account for
the increase in extracellular ATP levels. Moreover, ATP
measurements were performed on cells that had been
washed and incubated in the presence of fresh medium for
only 15 min. However, on the basis of numerous observations
obtained by different laboratories that have consistently corre-
lated the finding of an a-glycyrrhetinic acid-sensitive ATP
release to the presence of functional hemichannels (40), the
simplest interpretation of our data is that the two mutated
forms of Cx30 that are associated to HED not only form
typical, cell-to-cell gap junction channels, but also hemichan-
nels that show a propensity to open after insertion in the non-
junctional membrane. It is possible, therefore, that the in vivo
keratinocyte hyperproliferation observed in HED is due to an
uncontrolled release, via open hemichannels, of ATP and
other metabolites that may alter the paracrine signalling
within the epidermis.
Connexins are best known for their role in the formation of
channels between the cytoplasms of two adjacent cells, but
more recent studies have highlighted the ability of some
members of the connexin family to also form functional hemi-
channels (41). Thus, unpaired connexons have been shown to
be activated under a variety of experimental conditions (40,42)
and to play a role in the propagation of calcium waves through
ATP release (43,44). Hemichannel properties are similar to
those of paired connexons, and connexin-dependent ATP
release has been shown to be regulated by extra- and intra-
cellular calcium, at least in vitro (45,46). Abnormal ATP
leakage from keratinocytes, via mutated Cx30 hemichannels,
provides a conceivable molecular mechanism of HED.
Indeed, it has been shown that, in both normal and patho-
logical skin, extracellular ATP plays an important role in the
regulation of keratinocyte differentiation and proliferation
via the activation of specific purinergic receptors (47,48).
This mechanism may also be relevant for other connexin-
related skin diseases, inasmuch as mutations of Cx31, which
are responsible for EKV (10), are also lethal for HeLa cells
(47). Clearly, however, not all connexin mutations result in
the formation of such hemichannels, as exemplified by our
findings with the T5M mutation of Cx30. Thus, the mechan-
isms underlying the hearing loss phenotype associated to
T5M Cx30 differ from that causing HED, which results, in
vitro, in a toxic gain of function of the G11R and A88V
mutations that remains to be verified in vivo in the epidermis
of the HED patients. Another relevant point concerning the
study of these connexin mutations is that Cx30 has been
shown not only to interact with wt Cx26 but also with its
skin-related D66H mutated form, both in the inner ear and
in rodent skin (33,50). It is thus possible to imagine that
G11R and A88V Cx30 retain the ability to form heterotypic
channels with other connexins and that such interactions
might, for example, improve their trafficking to the membrane
and help to explain the absence of accumulation of mutated
Cx30 in the cytoplasm of affected keratinocytes.
Our results have uncovered a plausible mechanism under-
lying the development of HED and open new pathways to
be explored in the study of connexin pathology. Future
studies should establish whether other connexins expressed
in human skin (51,52), and notably those whose mutations
have been associated to genodermatosis (10), are also able
to form functional hemichannels and how they interact with
one another. If so, the specific physiological and pathophysio-
logical functions these hemichannels serve in epidermis will
have to be clarified.
Table 3. Effect of Cx30 mutations on cell survival
Transfected HeLa cells Control Wt Cx30 G11R Cx30 A88V Cx30 Wt Cx30 þ G11R Cx30 Wt Cx30 þ A88V Cx30
24 h % PIþ (SEM) 4.7 (3.9) 8.2 (4.7) 10.1 (6.0) 11.2 (2.8) 11.2 (0.6) 9.1 (4.3)
48 h % PIþ (SEM) 2.6 (4.2) 18.2 (7.2) 37.0 (11.2) 42.3 (11.5) 23.8 ,a (9.7) 30.1 ,b (6.4)
Percentage of propidium iodide-positive (PIþ) cells at 24 and 48 h following transfection; n ¼ 4 experiments. Controls are HeLa cells transfected with
a plasmid lacking the Cx30 insert.
P , 0.01 versus the corresponding control.
aNot significantly different from cells transfected with G11R Cx30 alone.
bNot significantly different from cells transfected with A88V Cx30 alone.
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MATERIALS AND METHODS
Cx30 constructs
The entire coding sequence of the wild-type human GJB6
gene was amplified by PCR from genomic DNA (using
sense primer: 50-GGATAAACCAGCGCAATG-30; antisense
primer: 50-GCTTGGGAAACCTGTGTATTG-30) and cloned
into the pcDNATM3.1/V5-His vector (Invitrogen), under
control of the CMV promoter (wtCx30-pcDNATM3.1/
V5-His). The insert’s open reading frame was cloned in phase
with the V5-His coding sequence of the vector. Specified
Cx30 mutations were obtained by site-directed mutagenesis
(QuickChange Site Directed Mutagenesis Kit, Stratagene)
using the following primers: for G11RCx30-pcDNATM3.1/
V5-His (sense: 50-CACTTTCATCAGGGGTGTCAACAAAC
ACTCC-30; antisense: 50-GGAGTGTTTGTTGACACCCCTG
ATGAAATGT-30); for A88VCx30-pcDNATM3.1/V5-His (sense:
50-CGTCTCCACCCCAGTGCTGCTGGTGGCC-30; antisense:
50-GGCCACCAGCAGCACTGGGGTGGAGACG-30); for T
5MCx30-pcDNATM3.1/V5-His (sense: 50-GGATTGGGGGA
TGCTGCACACT TTCATCGG-30; antisense: 50-CCGAT
GAAAGTGTGCAGCATCCCCCAATCC-30). In order to
reintroduce the original stop codon of Cx30, which had been
removed for cloning into the expression vector and thus
prevent the translation of the epitope tags, a fifth construct
(wtCx30-pcDNATM3.1/stop) was obtained using the
wtCx30-pcDNATM3.1/V5-His vector as the template, with
the following mutagenic primers (sense: 50-CACAGGTTT
CCCAAGCTAGGGCAATTCTGC-30; antisense: 50-GCAG
AATTGCCCTAGCTTGGGAAACCTGTG-30). All constructs
were verified for unwanted amino acid changes by automated
sequencing.
Cell culture and transfection
HeLa cells were cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum, 1 U/ml
penicillin and 1 mg/ml streptomycin. Cells were seeded 24 h
before transfection at a density of 104 cells/cm2. Transfection
was carried out using the EffecteneTM (Qiagen) transfection
reagent. Briefly, 100 000 cells were plated in 1.6 ml of
medium and 1 mg plasmid DNA was added to the supplied
buffer EC in a final volume of 50 ml, followed by 1.5 ml
Enhancer and 5 ml EffecteneTM transfection reagent. Culture
medium (600 ml) was then added to the mixture and the
reagents were added to the cells. About 55–65% of the cells
were positive for the transfected protein 24 h after transfection.
Antibodies and immunostaining
We used a rabbit polyclonal antibody against Cx30 purchased
from Zymed. The antibody against the V5 epitope was pur-
chased from Invitrogen. FITC-conjugated anti-rabbit IgG
and Cy3-conjugated anti-mouse IgG secondary antibodies
were purchased from Jackson Immunoresearch.
Paraffin-embedded samples of normal and pathological skin
were prepared as described (53). Primary antibody treatment
(1/200) was performed overnight at 48C and revealed using
the DAKO LSABw2 System. Briefly, slides were submitted
to 10 min incubations with biotin-linked antibodies and
peroxidase-labelled streptavidin followed by a diaminobenzi-
dine treatment and a final counterstaining using haematoxylin.
HeLa cells cultured on microscope cover slips were stained
24 h after transfection. Briefly, cells were rinsed twice in
phosphate-buffered saline (PBS) and kept for 3 min in
acetone at 2208C. After a 30 min wash in PBS supplemented
with 2% bovine serum albumin (BSA), cells were incubated
with both anti-Cx30 (1/200) and anti-V5 (1/500) antibodies
diluted in PBS–2%BSA for 2 h at room temperature. Cells
were rinsed in PBS and incubated with the FITC-conjugated
anti-rabbit antibodies and the Cy3-conjugated anti-mouse anti-
bodies for 1 h. After further washing, slides were mounted
using the DAPI-containing Vectashieldw mounting medium
(Vector).
Microinjection and dye transfer
For assessment of junctional coupling, individual cells were
microinjected by iontophoresis within 1-day-old cultures,
with either 4% LY CH (Sigma Chemical Co.) or a mixture
of 5% NB (Vector Laboratories) and 1% dextran–rhodamine
(Molecular Probes), as described (14,54). In the case of NB,
the cultures were fixed in a 4% solution of paraformaldehyde
in 0.1 M phosphate buffer, rinsed in PBS supplemented with
0.25% Triton X-100 (PBS-T) for 30 min, and exposed for
60 min to a fluorescein-conjugated streptavidin (Jackson
Immunoresearch Laboratories), diluted 1:300. In all cases,
the percentage of microinjections that resulted in cell-to-cell
transfer of each tracer, as well as the number of cells stained
by a gap junction tracer (1 cell ¼ no coupling) was determined
on photographs taken immediately after each microinjection
(54). Data were analyzed by the nonparametric chi square
test, as provided by the Statistical Package for Social Sciences
software (SPSS, Chicago).
Functional expression in Xenopus oocytes
The coding sequence of wt Cx30, G11R Cx30 and A88V
Cx30 were subcloned into the pSP64T expression vector
(55), and capped RNAs were produced using the mMessage
mMachine kit (Ambion). Stage V–VI oocytes were prepared
following previously described protocols (56). All cells were
injected with a total volume of 40 nl of either an antisense
oligonucleotide (3 ng/cell), to suppress the endogenous
Xenopus Cx38, or a mixture of antisense (as above) plus the
specified Cx30 RNA (0.5–40 ng/cell). In preliminary exper-
iments, we noticed that the injection of both G11R and
A88V Cx30 RNAs resulted in depigmentation, loss of mem-
brane potential and cellular lysis of most oocytes. These find-
ings suggested an abnormal opening of hemichannels in the
nonjunctional membrane, as already reported for other con-
nexins (30–32). Since currents of most connexins hemichan-
nels can be drastically reduced by raising extracellular Ca2þ
(35–39), all subsequent experiments were performed in MB
medium containing 2.9 mM Ca2þ.
For biochemical analysis, aliquots (300 ng) of in vitro
synthesized RNAs were translated in a rabbit reticulocyte
lysate system (Promega Corporation), in the presence of
[35S]methionine (New England Nuclear) and analyzed as pre-
viously described (57).
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The set-up, hardware and software used for electrophysio-
logical measurements and data analysis were as previously
described (58,59). To study the hemichannel activity of wt
and mutated Cx30, nonjunctional current recordings were
obtained from single oocytes 8–24 h after RNA injection,
using a two-electrode voltage-clamp procedure. Cells were
clamped at 240 mV, and whole cell currents recorded in res-
ponse to depolarizing voltage steps (from 220 to þ60 mV,
in 20 mV increments) imposed for 10 s. Current outputs
were sampled at 100 Hz, and the calculated peak values
above holding currents (DIm) were plotted against membrane
potential. The formation of intercellular channels was assessed
following previously described protocols (59). Data were
analyzed using Origin 6.0 (Microcal Software) and fit to a
Boltzmann relation as previously described (59). Results are
shown as mean + SEM. Statistical analysis was performed
using the Student’s unpaired t-test, with a significance
threshold set at P values of 0.05 or less.
Extracellular ATP measurements and
cell survival analysis
ATP release was measured 24 h after transfection. Cells were
cultured and transfected in 35 mm plates, rinsed twice in PBS
and incubated in 400 ml fresh medium for 15 min at 378C.
Then 90ml supernatant was collected and added to 90ml
nucleotide releasing reagent of the VialightTM HS kit (Biowhit-
taker). After 20 min, 20 ml ATP monitoring reagent was
added to the mixture, and luciferase activity was measured
for 10 s on a EG&G Berthold Microplate LB96V luminometer.
Connexin channels were blocked by incubating cells for
30 min in medium containing 50 mM a-glycyrrhetinic acid
(Sigma) (60). An aliquot of 400 ml of this medium was used
for the 15 min incubation preceding the measurement of
ATP release. Results were expressed as a mean + SEM per-
centage of the luciferase activity observed in mock-transfected
(exposure to transfection reagent without DNA) control
HeLa cells.
Viability of the transfected cells was assessed by staining
with the membrane-impermeable dye propidium iodide (PI).
Transfected cells were incubated for 24 and 48 h then rinsed
and treated with 500 ng/ml PI (Clontech) for 5 min. Dead
(PI-positive) and viable (PI-negative) cells were counted and
data were expressed as a percentage of total cells scored. Stat-
istical analysis was performed using a t-test for unpaired obser-
vations, with a P value ,0.01 considered to be significant.
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